1. Home
  2. Stock quotes
  3. PetMed Express
  4. Financial Statements
  5. Balance Sheet
PetMed Express logo
PetMed Express PETS
$ 3.16 -2.77%

Annual report 2025
added 10-14-2025

report update icon

PetMed Express Balance Sheet 2011-2026 | PETS

Annual Balance Sheet PetMed Express

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

 -53.7 M -53.8 M - - - -104 M -101 M -77.9 M -58.7 M -37.6 M -35.6 M -18.3 M -18.2 M -46.8 M -49.7 M

Long Term Debt

 535 K 995 K - - - - - - - - - - - - -

Long Term Debt Current

 461 K 459 K - - - - - - - - - - - - -

Total Non Current Liabilities

 - - - - - 970 K 1.12 M 996 K 1.09 M - - 65 K 168 K 492 K 321 K

Total Current Liabilities

 62.8 M 72.2 M 57.5 M 56.2 M 44.9 M 24.3 M 18.6 M 18.1 M 18.4 M - - 8.09 M 9 M 9.39 M -

Total Liabilities

 63.6 M 73.2 M 57.5 M 56.2 M 46.2 M 25.3 M 19.7 M 19.1 M 19.4 M 7.08 M 7.42 M 8.16 M 9.16 M 9.88 M 9.28 M

Deferred Revenue

 2.08 M 2.6 M - - - - - - - - - - - - -

Retained Earnings

 66.5 M 71.6 M 91.7 M 112 M 113 M 126 M 122 M 106 M 86.5 M 78.3 M 72.3 M 68.6 M 64 M 81.1 M 97.1 M

Total Assets

 149 M 170 M 167 M 180 M 187 M 155 M 154 M 135 M 113 M 90.3 M 82.9 M 78.4 M 73.2 M 91.1 M 106 M

Cash and Cash Equivalents

 54.7 M 55.3 M 104 M 111 M 119 M 104 M 101 M 77.9 M 58.7 M 37.6 M 35.6 M 18.3 M 18.2 M 46.8 M 49.7 M

Book Value

 85.1 M 96.7 M 110 M 123 M 141 M 130 M 135 M 116 M 93.4 M 83.2 M 75.4 M 70.2 M 64 M 81.2 M 97 M

Total Shareholders Equity

 85.1 M 96.7 M 110 M 123 M 125 M 130 M 135 M 116 M 93.4 M 83.2 M 75.4 M 70.2 M 64 M 81.2 M 97 M

All numbers in USD currency

Quarterly Balance Sheet PetMed Express

2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

 652 K 768 K 883 K 995 K 890 K 1.08 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

 48.6 M 49.6 M 59.2 M 73.2 M 73.3 M 45.6 M - 57.5 M 54.7 M 31.1 M - 34.1 M 27.5 M 17.9 M 33 M 46.2 M 28.2 M 22.5 M 29.9 M 25.3 M 21.8 M 19.9 M 21.2 M 19.7 M 24.1 M 18.2 M 28.8 M 19.1 M 25.6 M 20.6 M 26.6 M 19.4 M 8.24 M 8.56 M 13.4 M 7.08 M 7.71 M 9.16 M 15.6 M 7.42 M 6.3 M 7.58 M 13.9 M 8.16 M 6.34 M 10.7 M 15.4 M 9.16 M 8.66 M 9.25 M 11.9 M 9.88 M 8.59 M 9.04 M 13.3 M 9.28 M

Deferred Revenue

 1.16 M 1.65 M 2.15 M 2.6 M 3.07 M 3.57 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

 78.2 M 78.9 M 76.6 M 71.6 M 76.6 M 91.9 M - 91.7 M 98.2 M 123 M - 130 M 131 M 133 M 132 M 134 M 133 M 131 M 128 M 126 M 125 M 123 M 122 M 122 M 121 M 119 M 114 M 106 M 101 M 96.3 M 91.7 M 86.5 M 82.9 M 82 M 81 M 78.3 M 76.5 M 75.3 M 74.5 M 72.3 M 70.8 M 69.5 M 70.2 M 68.6 M 67.6 M 66.4 M 65.7 M 64 M 62.1 M 80 M 82 M 81.1 M 79.8 M 79.8 M 86.2 M 97.1 M

Total Assets

 145 M 146 M 153 M 170 M 173 M 159 M - 167 M 170 M 169 M - 176 M 168 M 159 M 173 M 187 M 167 M 159 M 163 M 155 M 150 M 146 M 145 M 154 M 157 M 148 M 153 M 135 M 136 M 125 M 126 M 113 M 97.6 M 96.5 M 99.8 M 90.3 M 88.6 M 88.4 M 93.4 M 82.9 M 79.8 M 79.4 M 86 M 78.4 M 75.1 M 77.8 M 81.4 M 73.2 M 70.7 M 89.4 M 94.5 M 91.1 M 88.4 M 88 M 99.4 M 106 M

Cash and Cash Equivalents

 50.1 M 52 M 46 M 55.3 M 49.4 M 53.5 M 61.5 M 104 M 102 M 96.5 M - 111 M 109 M 107 M 112 M 119 M 107 M 106 M 86.8 M 104 M 92.4 M 94.9 M 83.4 M 101 M 93.2 M 93.2 M 87.1 M 77.9 M 81 M 68.4 M 68.5 M 58.7 M 47.9 M 51.9 M 44.3 M 37.6 M 47.1 M 42.2 M 42.7 M 35.6 M 37.1 M 34.6 M 29.1 M 18.3 M 25.9 M 35.9 M 35 M 18.2 M 30 M 47 M 57.4 M 46.8 M 42 M 47.1 M 49.4 M 49.7 M

Book Value

 96.2 M 96.4 M 93.5 M 96.7 M 100 M 114 M - 110 M 115 M 138 M - 142 M 141 M 141 M 140 M 141 M 139 M 136 M 133 M 130 M 128 M 126 M 124 M 135 M 133 M 130 M 124 M 116 M 110 M 104 M 99 M 93.4 M 89.4 M 88 M 86.4 M 83.2 M 80.9 M 79.2 M 77.9 M 75.4 M 73.5 M 71.8 M 72.1 M 70.2 M 68.8 M 67.2 M 66.1 M 64 M 62.1 M 80.1 M 82.6 M 81.2 M 79.8 M 78.9 M 86.1 M 97 M

Total Shareholders Equity

 96.2 M 96.4 M 93.5 M 96.7 M 100 M 114 M - 110 M 115 M 138 M - 142 M 141 M 141 M 140 M 141 M 139 M 136 M 133 M 130 M 128 M 126 M 124 M 135 M 133 M 130 M 124 M 116 M 110 M 104 M 99 M 93.4 M 89.4 M 88 M 86.4 M 83.2 M 80.9 M 79.2 M 77.9 M 75.4 M 73.5 M 71.8 M 72.1 M 70.2 M 68.8 M 67.2 M 66.1 M 64 M 62.1 M 80.1 M 82.6 M 81.2 M 79.8 M 78.9 M 86.1 M 97 M

All numbers in USD currency

Balance Sheet is a fundamental financial report of PetMed Express, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Pharmaceutical retailers

Issuer Price % 24h Market Cap Country
Аптеки 36.6 Аптеки 36.6
APTK
 		- - - russiaRussia
China Jo-Jo Drugstores, Inc. China Jo-Jo Drugstores, Inc.
CJJD
 		- -5.59 % $ 49.9 M chinaChina
Greenlane Holdings Greenlane Holdings
GNLN
 		$ 1.57 -14.78 % $ 11.8 M usaUSA
BOQI International Medical BOQI International Medical
BIMI
 		- 6.33 % $ 5.86 M chinaChina
Trxade Group Trxade Group
MEDS
 		- 4.55 % $ 5.8 M usaUSA
LifeMD LifeMD
LFMD
 		$ 3.37 -3.35 % $ 114 M usaUSA
Rite Aid Corporation Rite Aid Corporation
RAD
 		- - $ 35.5 M usaUSA
111 111
YI
 		$ 2.5 -4.94 % $ 430 M chinaChina
Walgreens Boots Alliance Walgreens Boots Alliance
WBA
 		- - $ 10.3 B usaUSA